Pharmacokinetics, Safety Assessment and Residue Kinetics of Emamectin Benzoate in Rainbow Trout, Oncorhynchus mykiss (Walbaum, 1792)
Journal of Veterinary Pharmacology and Therapeutics · 2026
DOI: 10.1111/jvp.70068 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Veterinary Pharmacology and Therapeutics, 2026. Verfasst von Richa Pathak und 8 weiteren Autor:innen. Beteiligte Einrichtung: ICAR-Central Institute of Coldwater Fisheries Research (ICAR-CICFR), Anusandhan Bhavan, Bhimtal, Uttarakhand, India. Hauptthemen laut MEDLINE: Ivermectin, Oncorhynchus mykiss, Antiparasitic Agents. Die Arbeit nennt 78 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Indian Council of Agricultural Research.
Abstract (Originalsprache)
Emamectin benzoate (EB) is widely used in aquaculture to control ectoparasites. The study evaluated the pharmacokinetics, biosafety, and muscle residue depletion of EB. In pharmacokinetics, following administration of a single oral dose of 50 μg/kg EB, plasma and tissues (liver, kidney, gill, intestine, and muscle) were sampled up to 128 h and analysed using LC–MS/MS. EB showed tissue‐specific distribution, with the highest C max (565 μg/kg) and AUC (35,927.69 μg·h/kg) in kidney, and lowest C max (13.07 μg/kg) and AUC (368.40 μg·h/kg) in muscle. The intestine exhibited the longest half‐life (648.33 h), indicating prolonged retention. Biosafety was assessed at 1× (50 μg/kg), 5× (250 μg/kg), and 10× (500 μg/kg) doses for 21 days. Fish tolerated the therapeutic dose (1×) without behavioural abnormalities, while higher doses (5× and 10×) caused dose‐dependent pigmentation, reduced feed intake, and histopathological alterations in major organs. Muscle residues remained below the MRL (100 μg/kg) at the 1× dose. It declined below the MRL by day 21 in the 5× group, and reached below the MRL only by day 14 post‐dosing in the 10× group. These findings support the safe use of EB at recommended levels in rainbow trout, while higher doses increase toxicity and residue persistence.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- ICAR-Central Institute of Coldwater Fisheries Research (ICAR-CICFR), Anusandhan Bhavan, Bhimtal, Uttarakhand, India.
- ICAR-Central Institute of Brackishwater Aquaculture (ICAR-CIBA), Chennai, Tamil Nadu, India.
- ICAR Central Institute of Fisheries Technology (ICAR-CIFT), Kochi, India.
- ICAR-Indian Agricultural Research Institute (ICAR-IARI), Gauria Karma, Jharkhand, India.
ORCID-Profile: Richa Pathak, Prasanna Kumar Patil, Sumanta Kumar Mallik
Förderung
- Indian Council of Agricultural Research
Zitieren
APA
Pathak, R., Shahi, N., Patil, P. K., Kala, K., Chatterjee, N. S., Nadella, R. K., Kunal, K., Giri, A. K., & Mallik, S. K. (2026). Pharmacokinetics, Safety Assessment and Residue Kinetics of Emamectin Benzoate in Rainbow Trout, Oncorhynchus mykiss (Walbaum, 1792). Journal of Veterinary Pharmacology and Therapeutics. https://doi.org/10.1111/jvp.70068
Vancouver
Pathak R, Shahi N, Patil PK, Kala K, Chatterjee NS, Nadella RK, et al. Pharmacokinetics, Safety Assessment and Residue Kinetics of Emamectin Benzoate in Rainbow Trout, Oncorhynchus mykiss (Walbaum, 1792). Journal of Veterinary Pharmacology and Therapeutics. 2026. doi:10.1111/jvp.70068
BibTeX
@article{Pathak2026,
author = {Pathak, Richa and Shahi, Neetu and Patil, Prasanna Kumar and Kala, Krishna and Chatterjee, Niladri Sekhar and Nadella, Ranjit Kumar and Kunal, Kishor and Giri, Abhay Kumar and Mallik, Sumanta Kumar},
title = {Pharmacokinetics, Safety Assessment and Residue Kinetics of Emamectin Benzoate in Rainbow Trout, Oncorhynchus mykiss (Walbaum, 1792)},
journal = {Journal of Veterinary Pharmacology and Therapeutics},
year = {2026},
doi = {10.1111/jvp.70068}
}
EUVIMED